© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Dominik Mumberg, PhD
Articles
FGFR Inhibitor Shows Preclinical Activity in Breast Cancer
April 05, 2017
This video highlights preclinical activity of a novel FGFR inhibitor that has been tested alone and in combination with antihormonal therapy in breast cancer cell lines.